1. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up†;Dimopoulos;Ann Oncol,2021
2. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the international myeloma working group;Raje;Lancet Haemat,2022
3. Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma;Mohan;Br J Haematol,2023
4. FDA. FDA approves idecabtagene vicleucel for multiple myeloma. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-idecabtagene-vicleucel-multiple-myeloma. Accessed June 2 ,2024.
5. EMA. First cell-based gene therapy to treat adult patients with multiple myeloma. https://www.ema.europa.eu/en/news/first-cell-based-gene-therapy-treat-adult-patients-multiple-myeloma. Accessed June 2, 2024.